title: CMT/NSAID combination increases bone CMT uptake and inhibits bone resorption.
authors.affiliation: Department of Oral Biology & Pathology, School of Dental Medicine, SUNY, Stony Brook 11794-8702.
authors.forename: N
authors.initials: N
authors.lastname: Ramamurthy
authors.forename: M
authors.initials: M
authors.lastname: Leung
authors.forename: S
authors.initials: S
authors.lastname: Moak
authors.forename: R
authors.initials: R
authors.lastname: Greenwald
authors.forename: L
authors.initials: L
authors.lastname: Golub
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001862:Bone Resorption / Q000517:prevention & control*; D001842:Bone and Bones / Q000378:metabolism*; D004359:Drug Therapy, Combination; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D061965:Matrix Metalloproteinase Inhibitors; D000078183:Oxindoles; D051381:Rats; D011917:Rats, Inbred Lew; D013752:Tetracycline / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007211:Indoles; D061965:Matrix Metalloproteinase Inhibitors; D000078183:Oxindoles; C053450:4-des-dimethylaminotetracycline; C062866:tenidap; D013752:Tetracycline